The purpose of this study is to define seroprevalence of anti-SARS-CoV2 among children of Hospital Workers in APHP, particularly exposed population, according to parents' SARS-CoV2 serological status.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
563
Collect serum for Serology SARS-CoV2 at inclusion
Collect clinical and demographic data, habitus, Lifestyle Counseling at inclusion
Centre d'investigation clinique (CIC) Necker Cochin in Necker Children's Hospital
Paris, France
Seroprevalence of antibodies anti- SARS Cov2 in blood sample of children of Hospital workers
Percentage of children with seropositive in blood sample according to parents' SARS Cov2 serological status
Time frame: at inclusion
Seroprevalence of antibodies anti- SARS Cov2 in saliva sample of children of Hospital workers
Percentage of children with seropositive according in saliva sample to parents' SARS Cov2 serological status
Time frame: at inclusion
Number of Asymptomatic Children with a positive seroloy
Time frame: At inclusion
Number of severely symptomatic Children with a positive serology
Time frame: At inclusion
Prevalence of different clinical symptoms in children with a positive serology
Time frame: At inclusion
Serological result of each member of the family
Time frame: At inclusion
Number of spouses of hospital workers with a positive serology
Time frame: At inclusion
Number of Asymptomatic spouses of hospital workers with a positive serology
Time frame: At inclusion
Number of severely symptomatic spouses of hospital workers with a positive serology
Time frame: At inclusion
Comparison of Serological result obtained in blood and saliva samples
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: At inclusion
Risk factors based on a questionnaire for children and adults
the following factors will be of particular importance: characteristics and composition of the family home, barrier measures, medical history and comorbidities.
Time frame: At inclusion